Documentos relacionados

1. The Role of Natural Products in Drug Discovery and Development against Neglected Tropical Diseases.
2. AWZ1066S, a highly specific anti-<i>Wolbachia</i> drug candidate for a short-course treatment of filariasis.
3. Coverage of preventive measures and surveillance for neglected tropical diseases in hard-to-reach communities in Ghana.
4. Serological Evaluation of Onchocerciasis and Lymphatic Filariasis Elimination in the Bakoye and Falémé Foci, Mali.
5. Screening the Medicines for Malaria Venture Pathogen Box across Multiple Pathogens Reclassifies Starting Points for Open-Source Drug Discovery.
6. Semiannual Treatment of Albendazole Alone is Efficacious for Treatment of Lymphatic Filariasis: A Randomized Open-label Trial in Cote d'Ivoire.
7. Population Pharmacokinetics of Diethylcarbamazine in Patients with Lymphatic Filariasis and Healthy Individuals.
8. Evaluating the Diagnostic Test Accuracy of Molecular Xenomonitoring Methods for Characterizing Community Burden of Lymphatic Filariasis.
9. A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis.
10. The Health and Economic Burdens of Lymphatic Filariasis Prior to Mass Drug Administration Programs.